These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 1377152)
21. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464 [TBL] [Abstract][Full Text] [Related]
22. [Combined therapy of duodenal ulcer associated with Helicobacter pylori with electromagnetic decimeter waves and colloidal bismuth subcitrate]. Filimonov RM; Korolev IuN; Kochineva ER Vopr Kurortol Fizioter Lech Fiz Kult; 1993; (6):19-22. PubMed ID: 8154113 [No Abstract] [Full Text] [Related]
23. [The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate]. Zhang L; Zhang ST; Yu ZL; Shao Y Zhonghua Nei Ke Za Zhi; 2005 Apr; 44(4):272-5. PubMed ID: 15924641 [TBL] [Abstract][Full Text] [Related]
24. Synergism between clindamycin and colloidal bismuth subcitrate against Helicobacter (Campylobacter) pylori in vitro. Vogt K; Hahn H Zentralbl Bakteriol; 1990 Nov; 274(2):246-9. PubMed ID: 2085373 [TBL] [Abstract][Full Text] [Related]
25. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study. Kang JY; Tay HH; Wee A; Guan R; Math MV; Yap I Gut; 1990 Apr; 31(4):476-80. PubMed ID: 2186982 [TBL] [Abstract][Full Text] [Related]
26. Colloidal bismuth subcitrate and omeprazole inhibit alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori. Roine RP; Salmela KS; Höök-Nikanne J; Kosunen TU; Salaspuro M Life Sci; 1992; 51(21):PL195-200. PubMed ID: 1435071 [TBL] [Abstract][Full Text] [Related]
27. [Colloidal bismuth subcitrate and amoxicillin in the treatment of Helicobacter pylori infection in children]. Prieto Bozano G; Larrauri Martínez J; Bejarano López A; Lorente Miñarro M; Carrasco Gandía S; Polanco Allué I An Esp Pediatr; 1993 Jun; 38(6):525-8. PubMed ID: 8368681 [TBL] [Abstract][Full Text] [Related]
28. A scanning electron microscopic morphological and semi-quantitative evaluation of rat stomach treated with colloidal bismuth subcitrate and alcohol. Winters C; Hinsull SM; Gregory Z Scanning Microsc; 1991 Jun; 5(2):541-7; discussion 547-8. PubMed ID: 1947936 [TBL] [Abstract][Full Text] [Related]
29. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro. Slomiany BL; Nishikawa H; Bilski J; Slomiany A Am J Gastroenterol; 1990 Apr; 85(4):390-3. PubMed ID: 2109526 [TBL] [Abstract][Full Text] [Related]
30. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia]. Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420 [TBL] [Abstract][Full Text] [Related]
31. Bismuth absorption from the colloidal subcitrate. Hespe W; Staal HJ; Hall DW Lancet; 1988 Nov; 2(8622):1258. PubMed ID: 2903993 [No Abstract] [Full Text] [Related]
32. Effects of cagA+ and cagA- strains of Helicobacter pylori on the human gastric mucus layer thickness. Al-Marhoon MS; Nunn S; Soames RW J Gastroenterol Hepatol; 2005 Aug; 20(8):1246-52. PubMed ID: 16048574 [TBL] [Abstract][Full Text] [Related]
33. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori. Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111 [TBL] [Abstract][Full Text] [Related]
34. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Wagstaff AJ; Benfield P; Monk JP Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124 [TBL] [Abstract][Full Text] [Related]
35. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Dore MP; Graham DY; Mele R; Marras L; Nieddu S; Manca A; Realdi G Am J Gastroenterol; 2002 Apr; 97(4):857-60. PubMed ID: 12003419 [TBL] [Abstract][Full Text] [Related]
36. The subcellular localisation and the time course of bismuth in the gastric mucosa of rats after short-term administration of colloidal bismuth subcitrate. Ismail NM; Mustapha MS; Megat R Ann Acad Med Singap; 1997 Nov; 26(6):754-7. PubMed ID: 9522974 [TBL] [Abstract][Full Text] [Related]
37. Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate. Stiel D; Murray DJ; Peters TJ Gut; 1985 Apr; 26(4):364-8. PubMed ID: 3979909 [TBL] [Abstract][Full Text] [Related]
38. A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study. Ciccaglione AF; Cellini L; Grossi L; Manzoli L; Marzio L Helicobacter; 2015 Oct; 20(5):390-6. PubMed ID: 25801708 [TBL] [Abstract][Full Text] [Related]
39. Colloidal bismuth subcitrate, ranitidine, and ranitidine plus metronidazole in the treatment of duodenal ulcer and Helicobacter pylori infection: a controlled and prospective study. Huang CK; Chen GH Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jul; 52(1):15-20. PubMed ID: 8364776 [TBL] [Abstract][Full Text] [Related]
40. Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs. Wagner S; Beil W; Mai UE; Bokemeyer C; Meyer HJ; Manns MP Pharmacology; 1994 Oct; 49(4):226-37. PubMed ID: 7831386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]